Because the world can’t afford another COVID-19, we are working with a coalition of partners to help the global community be ready next time. We build support for robust disease surveillance networks and rapid response systems that can protect against future outbreaks wherever they may arise.
In July 2023, Revital Healthcare became the first-ever African manufacturer approved by the WHO to produce early activation auto-disable syringes—a milestone that will help diversify the geographic supplier base of…
The foundation has committed up to US$120 million to help ensure equitable global distribution of a promising new COVID-19 drug, molnupiravir. Here’s why that drug may be a game-changer in…
We know how to make smart investments in equitable economic recovery. If the IMF and the international community fail to act now, decades of development progress will be lost.
As the COVID-19 crisis continues, a well-coordinated global response is more important than ever. Drawing on insights from our broad array of partners, our foundation has identified a number of…
Now is the time to support developing countries in building the infrastructure, skills, and systems they need to develop safe and affordable vaccines for diseases that mostly affect poorer nations.
The world must act quickly to support African institutions in fighting the third wave of COVID-19 and bringing vaccines to the more than 98 percent of Africans who remain unvaccinated.
In the race against the coronavirus and its variants, wealthier countries must meet their vaccine-sharing commitments faster and pledge a greater share of their supply to low- and middle-income countries.
Data collected during the pandemic show just how much worse women have fared economically than men. Without urgent action, they will only fall further behind during the recovery.
The COVID-19 pandemic has largely affected women more than men. To build a strong economic recovery, data shows we must advance progress toward gender equality.
